Androgen receptor binding sites are highly mutated in prostate cancer
T. MOROVA, M. GÖNEN, A. GÜRSOY, O. KESKIN, N. A. LACK
The paper shows that AR binding sites in prostate cancer have high mutation rates, suggesting they may be driver mutations.
Oncology Abstracts · Sep 26, 2019Peer-reviewedCancer Biology